B6.129-Gba1tm1Karl/Kctt

Status

Available to order

EMMA IDEM:02452
Citation informationRRID:IMSR_EM:02452 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.129-Gba1tm1Karl/Kctt
Alternative nameGba flox/flox
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolGba1tm1Karl
Gene/Transgene symbolGba1

Information from provider

ProviderStefan Karlsson
Provider affiliationInstitute of Laboratory Medicine, The Lund Strategic Center for Stem Cell Biology and Cell Therapy
Genetic informationExons 9-11 of Gba1 (Gba or GCase) gene are flanked by loxP sites. The flox/flox mice are bred with Mx1-cre mice to enable deletion of the GCase exons 9-11 after birth, thereby maintaining GCase activity during development and avoiding disruption of the skin barrier.
Phenotypic informationHomozygous GCase flox/flox Mx1-cre+ mice will develop Gaucher disease type 1 after induction of the loxP system. Mice have normal lifespan.
Breeding historyBackcrossed for 11 generations.
References
  • Murine models of acute neuronopathic Gaucher disease.;Enquist Ida Berglin, Lo Bianco Christophe, Ooka Andreas, Nilsson Eva, Månsson Jan-Eric, Ehinger Mats, Richter Johan, Brady Roscoe O, Kirik Deniz, Karlsson Stefan, ;2007;Proceedings of the National Academy of Sciences of the United States of America;104;17483-8; 17954912
  • Effective cell and gene therapy in a murine model of Gaucher disease.;Enquist Ida Berglin, Nilsson Eva, Ooka Andreas, Månsson Jan-Eric, Olsson Karin, Ehinger Mats, Brady Roscoe O, Richter Johan, Karlsson Stefan, ;2006;Proceedings of the National Academy of Sciences of the United States of America;103;13819-24; 16954197

Information from EMMA

Archiving centreKarolinska Institutet, Stockholm, Sweden

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • increased circulating amylase level / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • prolonged QRS complex duration / IMPC
MGI phenotypes (gene matching)
  • decreased hematocrit / MGI
  • decreased leukocyte cell number / MGI
  • enlarged liver / MGI
  • abnormal liver physiology / MGI
  • abnormal spleen morphology / MGI
  • reddish skin / MGI
  • abnormal skin condition / MGI
  • wrinkled skin / MGI
  • thick epidermis / MGI
  • hyperkeratosis / MGI
  • decreased body weight / MGI
  • dehydration / MGI
  • aphagia / MGI
  • cyanosis / MGI
  • anemia / MGI
  • abnormal inflammatory response / MGI
  • liver inflammation / MGI
  • lung inflammation / MGI
  • abnormal respiration / MGI
  • perinatal lethality / MGI
  • abnormal brain morphology / MGI
  • no abnormal phenotype detected / MGI
  • abnormal pulmonary circulation / MGI
  • abnormal lymph node morphology / MGI
  • abnormal macrophage morphology / MGI
  • increased IgG level / MGI
  • akinesia / MGI
  • decreased hemoglobin content / MGI
  • decreased erythrocyte cell number / MGI
  • increased circulating alanine transaminase level / MGI
  • increased liver weight / MGI
  • astrocytosis / MGI
  • decreased skin turgor / MGI
  • dry skin / MGI
  • lymph node inflammation / MGI
  • increased hepatocyte apoptosis / MGI
  • abnormal striatum morphology / MGI
  • skin inflammation / MGI
  • increased spleen weight / MGI
  • decreased circulating cholesterol level / MGI
  • increased circulating aspartate transaminase level / MGI
  • skeleton phenotype / MGI
  • abnormal food intake / MGI
  • abnormal enzyme/coenzyme activity / MGI
  • abnormal Kupffer cell morphology / MGI
  • alpha-synuclein inclusion body / MGI
  • abnormal spleen physiology / MGI
  • decreased survivor rate / MGI
  • lipofuscinosis / MGI
  • absent gastric milk in neonates / MGI
  • decreased birth weight / MGI
  • decreased birth body size / MGI
  • postnatal lethality, complete penetrance / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • neonatal lethality, complete penetrance / MGI
  • perinatal lethality, complete penetrance / MGI

Literature references

  • Murine models of acute neuronopathic Gaucher disease.;Enquist Ida Berglin, Lo Bianco Christophe, Ooka Andreas, Nilsson Eva, Månsson Jan-Eric, Ehinger Mats, Richter Johan, Brady Roscoe O, Kirik Deniz, Karlsson Stefan, ;2007;Proceedings of the National Academy of Sciences of the United States of America;104;17483-8; 17954912
  • Effective cell and gene therapy in a murine model of Gaucher disease.;Enquist Ida Berglin, Nilsson Eva, Ooka Andreas, Månsson Jan-Eric, Olsson Karin, Ehinger Mats, Brady Roscoe O, Richter Johan, Karlsson Stefan, ;2006;Proceedings of the National Academy of Sciences of the United States of America;103;13819-24; 16954197

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).